Literature DB >> 30775879

PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic Characteristics.

Biao Wang, Lingyan Xu, Yugang Ge, Xiaomin Cai, Qiang Li, Zhengyi Yu, Jiawei Wang, Ying Wang, Chao Lu, Danping Wang, Yuanyuan Wang, Xiaofeng Chen, Yanhong Gu.   

Abstract

BACKGROUND: Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3) has been proven to be involved in various human cancers; however, the function of PLOD3 in gastric cancer (GC) remains unclear. In this study, the role of PLOD3 in GC was evaluated.
METHODS: The expression of PLOD3 in GC tissues and normal tissues was predicted by The Cancer Genome Atlas (TCGA). The kmplot online tool was performed to evaluate the impact of PLOD3 expression on GC patients' survival. Real-time PCR was conducted to verify PLOD3 expression in our own clinical samples and GC cells. The Cell Counting Kit-8 and the colony formation assay were used to detect GC cell proliferation ability.
RESULTS: PLOD3 was upregulated in human GC tissues (compared to adjacent normal tissues, p < 0.001) and GC cells. High expression of PLOD3 was significantly correlated with larger tumor size (p = 0.007) and poor prognosis. Inhibition of PLOD3 could suppress cell proliferation in GC.
CONCLUSIONS: These results revealed that PLOD3 may promote the progression of GC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30775879     DOI: 10.7754/Clin.Lab.2018.180541

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  8 in total

1.  PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma.

Authors:  Siming Gong; Nikolas Schopow; Yingjuan Duan; Changwu Wu; Sonja Kallendrusch; Georg Osterhoff
Journal:  Genes (Basel)       Date:  2022-04-28       Impact factor: 4.141

2.  Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methods.

Authors:  Yonghui Zhao; Xiang Zhang; Junchao Yao
Journal:  PLoS One       Date:  2021-01-27       Impact factor: 3.240

3.  An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma.

Authors:  Yingzhen Gao; Liuyi Shen; Tianyue Dong; Xin Yang; Heyang Cui; Yanlin Guo; Yanchun Ma; Pengzhou Kong; Xiaolong Cheng; Ling Zhang; Yongping Cui
Journal:  J Transl Med       Date:  2022-06-25       Impact factor: 8.440

4.  A Fe2+-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes.

Authors:  Luigi Scietti; Elisabetta Moroni; Daiana Mattoteia; Marco Fumagalli; Matteo De Marco; Lisa Negro; Antonella Chiapparino; Stefano A Serapian; Francesca De Giorgi; Silvia Faravelli; Giorgio Colombo; Federico Forneris
Journal:  Front Mol Biosci       Date:  2022-08-25

5.  Overexpressing PLOD family genes predict poor prognosis in gastric cancer.

Authors:  Shan-Shan Li; Yi-Fan Lian; Yan-Lin Huang; Yue-Hua Huang; Jian Xiao
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

6.  A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).

Authors:  Siming Gong; Yingjuan Duan; Changwu Wu; Georg Osterhoff; Nikolas Schopow; Sonja Kallendrusch
Journal:  Int J Mol Sci       Date:  2021-09-14       Impact factor: 5.923

7.  Exploration of the typical features of tubulovillous adenoma using in-depth quantitative proteomics analysis.

Authors:  Yin Zhang; Meng Pan; Chun-Yuan Li; Jing-Ying Li; Wei Ge; Lai Xu; Yi Xiao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.

Authors:  Jing Zhang; YanZhang Tian; ShaoJian Mo; XiFeng Fu
Journal:  Int J Gen Med       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.